Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non–Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial

PURPOSE: Patients with centrally located early-stage non–small-cell lung cancer (NSCLC) are at a higher risk of toxicity from high-dose ablative radiotherapy. NRG Oncology/RTOG 0813 was a phase I/II study designed to determine the maximum tolerated dose (MTD), efficacy, and toxicity of stereotactic...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Clin Oncol
Main Authors: Bezjak, Andrea, Paulus, Rebecca, Gaspar, Laurie E., Timmerman, Robert D., Straube, William L., Ryan, William F., Garces, Yolanda I., Pu, Anthony T., Singh, Anurag K., Videtic, Gregory M., McGarry, Ronald C., Iyengar, Puneeth, Pantarotto, Jason R., Urbanic, James J., Sun, Alexander Y., Daly, Megan E., Grills, Inga S., Sperduto, Paul, Normolle, Daniel P., Bradley, Jeffrey D., Choy, Hak
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2019
Teme:
ORIGINAL REPORTS
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6524984/
https://ncbi.nlm.nih.gov/pubmed/30943123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.18.00622
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki